Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer

NCT03734692 is registered in ClinicalTrials.gov with Robert Edwards as lead sponsor.

NCT NCT03734692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03734692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer
Lead sponsor
Robert Edwards
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
January 28, 2019
Completion date
January 10, 2027
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer recurrent